Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Rxsight Inc (RXST)

Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,024,353
  • Shares Outstanding, K 36,988
  • Annual Sales, $ 89,080 K
  • Annual Income, $ -48,610 K
  • EBIT $ -42 M
  • EBITDA $ -44 M
  • 60-Month Beta 1.19
  • Price/Sales 21.48
  • Price/Cash Flow N/A
  • Price/Book 6.95

Options Overview Details

View History
  • Implied Volatility 116.05% ( -0.58%)
  • Historical Volatility 38.26%
  • IV Percentile 96%
  • IV Rank 67.53%
  • IV High 153.08% on 08/05/24
  • IV Low 39.03% on 05/22/24
  • Put/Call Vol Ratio 2.56
  • Today's Volume 5,252
  • Volume Avg (30-Day) 647
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 10,050
  • Open Int (30-Day) 6,686

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.19
  • Number of Estimates 3
  • High Estimate -0.18
  • Low Estimate -0.21
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +45.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.68 +6.65%
on 10/23/24
55.57 -8.49%
on 11/07/24
+2.61 (+5.41%)
since 10/07/24
3-Month
46.52 +9.31%
on 10/02/24
58.23 -12.67%
on 08/26/24
+4.61 (+9.97%)
since 08/07/24
52-Week
22.91 +121.96%
on 11/10/23
66.54 -23.58%
on 05/07/24
+25.81 (+103.08%)
since 11/07/23

Most Recent Stories

More News
RxSight, Inc. Reports Third Quarter 2024 Financial Results

RXST : 50.85 (-7.09%)
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

RXST : 50.85 (-7.09%)
3 Growth Stocks to Grab for 29% Upside or More

These three promising growth stocks could deliver upside of 29% or more, according to analysts’ estimates.

ZS : 196.71 (+1.91%)
NTNX : 70.45 (+5.48%)
RXST : 50.85 (-7.09%)
NVDA : 148.88 (+2.25%)
$SPX : 5,973.10 (+0.74%)
AZPN : 245.97 (+0.67%)
Chart of the Day: RxSight - Cashing In On Cataracts

The Chart of the Day belongs to the ophthalmic devices company RxSight (RXST) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals,...

RXST : 50.85 (-7.09%)
RxSight, Inc. (RXST) Q2 2022 Earnings Call Transcript

RXST earnings call for the period ending June 30, 2022.

RXST : 50.85 (-7.09%)
RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program

ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 50.85 (-7.09%)
RxSight, Inc. Reports Second Quarter 2022 Financial Results

ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 50.85 (-7.09%)
RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022

ALISO VIEJO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 50.85 (-7.09%)
RxSight, Inc. (RXST) Q1 2022 Earnings Call Transcript

RXST earnings call for the period ending March 31, 2022.

RXST : 50.85 (-7.09%)
RxSight, Inc. to Present at the Bank of America Healthcare Conference

ALISO VIEJO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 50.85 (-7.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif.

See More

Key Turning Points

3rd Resistance Point 59.81
2nd Resistance Point 57.69
1st Resistance Point 54.27
Last Price 50.85
1st Support Level 48.73
2nd Support Level 46.61
3rd Support Level 43.19

See More

52-Week High 66.54
Last Price 50.85
Fibonacci 61.8% 49.87
Fibonacci 50% 44.72
Fibonacci 38.2% 39.58
52-Week Low 22.91

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar